This inventor holds 2 USPTO granted patents. Top assignee: Zentaris Ag. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2004
Title: The Innovative Mind of Alfred Popp
Introduction
Alfred Popp, an accomplished inventor based in Burghausen, Germany, has made significant contributions to the field of pharmaceuticals through his innovative research. With a focus on indole derivatives, Popp has dedicated his efforts to finding treatments for malignant and other diseases associated with pathological cell proliferation. His work reflects his commitment to improving healthcare outcomes through novel inventions.
Latest Patents
Alfred Popp holds two patents, which highlight his groundbreaking research in the area of indole derivatives. His latest patents are titled "Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation" and "Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation." Both patents showcase potential therapeutic applications that could significantly advance treatment methodologies in oncology and related fields.
Career Highlights
Popp is currently associated with Zentaris AG, a company known for specializing in innovative approaches to healthcare. His tenure at Zentaris AG has enabled him to collaborate with other talented professionals in the field, further enhancing his contributions to science and medicine.
Collaborations
Throughout his career, Alfred Popp has worked alongside notable colleagues, including Siavosh Mahboobi and Sabine Kuhr. This dynamic teamwork has fostered an environment of creativity and innovation, allowing them to make significant strides in research and development.
Conclusion
Alfred Popp's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only reflect his inventive capabilities but also carry the potential to transform treatment options for patients worldwide. As he continues to develop new solutions, the contributions of inventors like Popp are crucial in the journey toward advancing healthcare innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile